CIBC Asset Management
SLXP

CIBC Asset Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

CIBC Asset Management’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,767
Closed -$305K – 1013
2015
Q1 		$305K Buy
1,767
+14
+0.8% +$2.06K ﹤0.01% 783
2014
Q4 		$201K Sell
1,753
-235
-12% -$28.5K ﹤0.01% 884
2014
Q3 		$311K Buy
+1,988
New +$288K ﹤0.01% 792
2014
Q2 		– Sell
-1,988
Closed -$206K – 995
2014
Q1 		$206K Buy
+1,988
New +$204K ﹤0.01% 935

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

CIBC Asset Management's SLXP Position: Q2 2015 in Review

CIBC Asset Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 1,767 shares — an estimated $305K sold.

CIBC Asset Management first reported a position in SLXP in Q1 2014 and held it in 4 quarters. The position peaked at $311K in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • CIBC Asset Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • CIBC Asset Management sold 1,767 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $305K.
  • CIBC Asset Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q1 2014 and held it in 4 quarters.
  • CIBC Asset Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $311K in Q3 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on CIBC Asset Management's 13F filing for Q2 2015, filed 6 Aug 2015.